Umbilical Cord Tissue Banking
Mycord is continuously engaged in extensive research. It has the expertise to utilize umbilical cord tissue derived stem cells for therapy. As such, Mycord has made provision to bank isolated umbilical cord tissue derived Mesenchymal stem cells (MSCs).
It is evident through research that stem cells first isolated and then stored are more potent and viable as compared to stem cells harvested from directly banked cord.
Mesenchymal stem cells have great potential to treat various degenerative disorders of the body such as osteoarthritis, neurodegenerative conditions, optic nerve atrophy, autism, etc to name a few. Over 600 clinical trials are underway exploring the safety and efficacy of MSC based therapies.
Amniotic Membrane Banking- A New Discovery
Amniotic membrane, the innermost layer of the placenta, which protects the fetus during its development in the womb, can now be utilized to protect the family.
Mycord has for the first time in India developed technology and expertise to bank this precious membrane exclusively for the use of the family in the future. This biological scaffold seeded with stem cells and growth factors has tremendous potential for skin regeneration in burns, injury, scarring etc. As it is immune privileged it can be used by any member of the family without risk of rejection. Mycord has published the protocol for isolation, processing and storage of Amniotic membrane in an international journal.
Direct Cord Storage
Apart from isolating the MSCs from the cord, Mycord also follows the policy of direct storage of the rest of the umbilical cord for possible future use. As the wheels of research in this field are turning fast, there could be properties other than stem cells in the cord tissue that could benefit the family in years to come.